The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter
Open accessAbstract
Antibiotics changed medical practice by significantly decreasing the morbidity and mortality associated with bacterial infection. However, infectious diseases remain the leading cause of death in the world. There is global concern about the rise in antimicrobial resistance (AMR), which affects both developed and developing countries. AMR is a public health challenge with extensive health, economic, and societal implications. This paper sets AMR in context, starting with the history of antibiotics, including the discovery of penicillin and the golden era of antibiotics, before exploring the problems and challenges we now face due to AMR. Among the factors discussed is the low level of development of new antimicrobials and the irrational prescribing of antibiotics in developed and developing countries. A fundamental problem is the knowledge, attitude, and practice (KAP) regarding antibiotics among medical practitioners, and we explore this aspect in some depth, including a discussion on the KAP among medical students. We conclude with suggestions on how to address this public health threat, including recommendations on training medical students about antibiotics, and strategies to overcome the problems of irrational antibiotic prescribing and AMR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Antimicrobial resistance: a global multifaceted phenomenon
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000030 · Cited by 3,296
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Understanding the mechanisms and drivers of antimicrobial resistance
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00473-0 · Cited by 2,611
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Llor, C., & Bjerrum, L. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614554919 · Cited by 2,079 · cited 1×
“Profitability is affected by the speed with which microbes develop resistance to newly introduced antimicrobials, thereby severely restricting sales of the drug (161, 166, 169, 170).”
BackgroundAntibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
An overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Katzung, B. G. (2018) · Cited by 1,377
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
The threat of antimicrobial resistance in developing countries: causes and control strategies
Ayukekbong, J. A., Ntemgwa, M., & Atabe, A. N. (2017) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-017-0208-x · Cited by 1,315
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
Siderophores in environmental research: roles and applications
Ahmed, E., & Holmström, S. J. M. (2014) · Microbial Biotechnology · doi:10.1111/1751-7915.12117 · Cited by 1,096
WHO PUBLISHES LIST OF BACTERIA FOR WHICH NEW ANTIBIOTICS ARE URGENTLY NEEDED
City, P. S. M. M. (2017) · Cited by 1,071
Antimicrobial resistance: A global emerging threat to public health systems
Ferri, M., Ranucci, E., Romagnoli, P., & Giaccone, V. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077192 · Cited by 1,049
Origins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 1,033
Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
Arias, C. A., & Murray, B. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0804651 · Cited by 1,027
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Non-prescription antimicrobial use worldwide: a systematic review
Morgan, D. J., Okeke, I. N., Laxminarayan, R., Perencevich, E. N., & Weisenberg, S. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70054-8 · Cited by 947
Opportunities and challenges in phenotypic drug discovery: an industry perspective
Moffat, J. G., Vincent, F., Lee, J. A., Eder, J., & Prunotto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.111 · Cited by 939
Li, B., & Webster, T. J. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23656 · Cited by 907
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Past and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Further Observations on Penicillin
Abraham, E. P., Chain, E., Fletcher, C. M., Gardner, A. D., Heatley, N. G., Jennings, M. A., & Florey, H. W. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72122-2 · Cited by 821
Horizontal transfer of antibiotic resistance genes in clinical environments
Lerminiaux, N. A., & Cameron, A. D. S. (2019) · Canadian Journal of Microbiology · doi:10.1139/cjm-2018-0275 · Cited by 802
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
The evolving threat of antimicrobial resistance: Options for action
Kapi, A. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 714
The future challenges facing the development of new antimicrobial drugs
Coates, A., Hu, Y., Bax, R., & Page, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd940 · Cited by 704
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Kitawaki, J., & Unemo, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-11 · Cited by 686
Global Contributors to Antibiotic Resistance
Chokshi, A., Sifri, Z., Cennimo, D., & Horng, H. (2019) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_110_18 · Cited by 647
Vital signs: carbapenem-resistant Enterobacteriaceae.
(2013) · PubMed Central · Cited by 604
Ellington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
Novel classes of antibiotics or more of the same?
Coates, A. R., Halls, G., & Hu, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01250.x · Cited by 598
The Discovery of Penicillin—New Insights After More Than 75 Years of Clinical Use
Gaynes, R. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2305.161556 · Cited by 597
Cock, I., Cheesman, M., Ilanko, A., & Blonk, B. (2017) · Pharmacognosy Reviews · doi:10.4103/phrev.phrev_21_17 · Cited by 550
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. B. (1988) · PubMed · Cited by 532
Trimethoprim and sulfonamide resistance.
Huovinen, P., Sundström, L., Swedberg, G., & Sköld, O. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.279 · Cited by 523
The Perpetual Challenge of Infectious Diseases
Fauci, A. S., & Morens, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1108296 · Cited by 517
Andersson, M. I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg212 · Cited by 503
Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci
Kirby, W. M. M. (1944) · Science · doi:10.1126/science.99.2579.452 · Cited by 502
Resistance to Trimethoprim-Sulfamethoxazole
Eliopoulos, G. M., & Huovinen, P. (2001) · Clinical Infectious Diseases · doi:10.1086/320532 · Cited by 500
Shields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 484
The macrolide antibiotic renaissance
Dinos, G. P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13936 · Cited by 471
Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09
Shapiro, D. J., Hicks, L. A., Pavia, A. T., & Hersh, A. L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt301 · Cited by 466
Zhanel, G. G., Golden, A. R., Zelenitsky, S., Wiebe, K., Lawrence, C. K., Adam, H. J., Idowu, T., Domalaon, R., Schweizer, F., Zhanel, M. A., et al. (2019) · Drugs · doi:10.1007/s40265-019-1055-2 · Cited by 446
Nation, R. L., & Li, J. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328332e672 · Cited by 443
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Antimicrobial resistance in developing countries and responsible risk factors
Byarugaba, D. K. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.02.015 · Cited by 409
The natural history of antibiotics
Clardy, J., Fischbach, M. A., & Currie, C. R. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.001 · Cited by 402
Drivers of Irrational Use of Antibiotics in Europe
Machowska, A., & Stålsby Lundborg, C. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16010027 · Cited by 383
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
Sato, T., & Yamawaki, K. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz826 · Cited by 379
Zhanel, G. G., Lawrence, C. K., Adam, H., Schweizer, F., Zelenitsky, S., Zhanel, M., Lagacé-Wiens, P. R. S., Walkty, A., Denisuik, A., Golden, A., et al. (2018) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 377
INFECTION BY PENICILLIN-RESISTANT STAPHYLOCOCCI
Barber, M., & Rozwadowska-Dowzenko, M. (1948) · The Lancet · doi:10.1016/s0140-6736(48)92166-7 · Cited by 368
Guide to good prescribing : a practical manual
Action Programme on Essential Drugs, & de Vries, T. P. G. M. (1995) · Medical Entomology and Zoology · Cited by 354
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Ribeiro da Cunha, B., Fonseca, L. P., & Calado, C. R. C. (2019) · Antibiotics · doi:10.3390/antibiotics8020045 · Cited by 353
Alexander Fleming (1881–1955): Discoverer of penicillin
Tan, S., & Tatsumura, Y. (2015) · Singapore Medical Journal · doi:10.11622/smedj.2015105 · Cited by 342
Doi, Y., Wachino, J.-I., & Arakawa, Y. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.011 · Cited by 341
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Natural products — The future scaffolds for novel antibiotics?
Butler, M. S., & Buss, A. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 337
Promoting rational prescribing: an international perspective.
Hogerzeil, H. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04402.x · Cited by 333
Molecular mechanisms related to colistin resistance in Enterobacteriaceae
Aghapour, Z., Gholizadeh, P., Ganbarov, K., bialvaei, A. Z., Mahmood, S. S., Tanomand, A., Yousefi, M., Asgharzadeh, M., Yousefi, B., & Samadi Kafil, H. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s199844 · Cited by 320
Paterson, D. L. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00107.x · Cited by 310
Use and Prescription of Antibiotics in Primary Health Care Settings in China
Wang, J., Wang, P., Wang, X., Zheng, Y., & Xiao, Y. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5214 · Cited by 307
Schatz, A., Bugie, E., Waksman, S. A., Hanssen, A. D., Patel, R., & Osmon, D. R. (2005) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000175887.98112.fe · Cited by 305
Pankey, G. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki248 · Cited by 301
The ins and outs of RND efflux pumps in Escherichia coli
Anes, J., McCusker, M. P., Fanning, S., & Martins, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00587 · Cited by 293
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Kreiswirth, B. N., & Clancy, C. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02497-17 · Cited by 289
Irrational Use of Medicines—A Summary of Key Concepts
Ofori-Asenso, R., & Agyeman, A. (2016) · Pharmacy · doi:10.3390/pharmacy4040035 · Cited by 287
How to educate prescribers in antimicrobial stewardship practices
Pulcini, C., & Gyssens, I. C. (2013) · Virulence · doi:10.4161/viru.23706 · Cited by 286
Something old, something new: revisiting natural products in antibiotic drug discovery
Wright, G. D. (2014) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0063 · Cited by 283
Bedaquiline: First FDA-approved tuberculosis drug in 40 years
Mahajan, R. (2013) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.112228 · Cited by 271
Intervention Research in Rational Use of Drugs: A Review
Le Grand, A., Hogerzeil, H. V., & Haaijer-Ruskamp, F. M. (1999) · Health Policy and Planning · doi:10.1093/heapol/14.2.89 · Cited by 268
Antibiotics: from prehistory to the present day
Gould, K. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv484 · Cited by 268
Antibiotic overuse: a key driver of antimicrobial resistance
Shallcross, L. J., & Davies, D. S. C. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x682561 · Cited by 267
Knowledge, attitude and practice of antibiotics: a questionnaire study among 2500 Chinese students
Huang, Y., Gu, J., Zhang, M., Ren, Z., Yang, W., Chen, Y., Fu, Y., Chen, X., Cals, J. W., & Zhang, F. (2013) · BMC Medical Education · doi:10.1186/1472-6920-13-163 · Cited by 257
Resistance to vancomycin and teicoplanin: an emerging clinical problem
Johnson, A. P., Uttley, A. H., Woodford, N., & George, R. C. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.3.280 · Cited by 245
Treatment of Tuberculosis. A Historical Perspective
Murray, J. F., Schraufnagel, D. E., & Hopewell, P. C. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201509-632ps · Cited by 245
Plasmid persistence: costs, benefits, and the plasmid paradox
Carroll, A. C., & Wong, A. (2018) · Canadian Journal of Microbiology · doi:10.1139/cjm-2017-0609 · Cited by 245
Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241
Discovery and development of new antibacterial drugs: learning from experience?
Jackson, N., Czaplewski, L., & Piddock, L. J. V. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky019 · Cited by 238
Ceftriaxone-Resistant Neisseria gonorrhoeae , Japan
Ohnishi, M., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Watanabe, H., & Kitawaki, J. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.100397 · Cited by 236
Where Have all the Antibiotics Gone?
Davies, J. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2006/707296 · Cited by 228
Performance of retail pharmacies in low- and middle-income Asian settings: a systematic review
Miller, R., & Goodman, C. (2016) · Health Policy and Planning · doi:10.1093/heapol/czw007 · Cited by 225
Antimicrobial drug development – the past, the present, and the future
Powers, J. H. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1465-0691.2004.1007.x · Cited by 224
Grigoryan, L., Burgerhof, J. G. M., Degener, J. E., Deschepper, R., Lundborg, C. S., Monnet, D. L., Scicluna, E. A., Birkin, J., Haaijer-Ruskamp, F. M., & on behalf of the Self-Medication with Antibiotics and Resistance (SAR) Consortium (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn054 · Cited by 224
Giddins, M. J., Macesic, N., Annavajhala, M. K., Stump, S., Khan, S., McConville, T. H., Mehta, M., Gomez-Simmonds, A., & Uhlemann, A.-C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-17 · Cited by 219
Novel approaches to developing new antibiotics for bacterial infections
Coates, A. R. M., & Hu, Y. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707432 · Cited by 218
Technologies to address antimicrobial resistance
Baker, S. J., Payne, D. J., Rappuoli, R., & De Gregorio, E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717160115 · Cited by 215
Srinivasan, A., Song, X., Richards, A., Sinkowitz-Cochran, R., Cardo, D., & Rand, C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1451 · Cited by 211
THE TREASURE CALLED ANTIBIOTICS.
Adedeji, W. A. (2016) · PubMed Central · Cited by 209
Oates, J. A., Wood, A. J. J., Donowitz, G. R., & Mandell, G. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802253180806 · Cited by 208
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China
Zhang, P., Shi, Q., Hu, H., Hong, B., Wu, X., Du, X., Akova, M., & Yu, Y. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.08.020 · Cited by 200
Lahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03057-14 · Cited by 197
Dyar, O. J., Pulcini, C., Howard, P., Nathwani, D., ESGAP, O. B. O., (the ESCMID Study Group for Antibiotic Policies), Nathwani, D., Beovic, B., Pulcini, C., Harbarth, S., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt440 · Cited by 194
The Pharmaceutical Industry and the Future of Drug Development
Taylor, D. (2015) · Pharmaceuticals in the Environment · doi:10.1039/9781782622345-00001 · Cited by 192
Self-medication with antibiotics—Does it really happen in Europe?
Väänänen, M. H., Pietilä, K., & Airaksinen, M. (2006) · Health Policy · doi:10.1016/j.healthpol.2005.07.001 · Cited by 186
Where are all the new antibiotics? The new antibiotic paradox
Conly, J., & Johnston, B. (2005) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2005/892058 · Cited by 186
Understanding drivers of antibiotic resistance genes in High Arctic soil ecosystems
McCann, C. M., Christgen, B., Roberts, J. A., Su, J.-Q., Arnold, K. E., Gray, N. D., Zhu, Y.-G., & Graham, D. W. (2019) · Environment International · doi:10.1016/j.envint.2019.01.034 · Cited by 184
Tetracycline-Labeled Human Bone from Ancient Sudanese Nubia (A.D. 350)
Bassett, E. J., Keith, M. S., Armelagos, G. J., Martin, D. L., & Villanueva, A. R. (1980) · Science · doi:10.1126/science.7001623 · Cited by 180
Medicines Regulation in Africa: Current State and Opportunities
Ndomondo-Sigonda, M., Miot, J., Naidoo, S., Dodoo, A., & Kaale, E. A. (2017) · Pharmaceutical Medicine · doi:10.1007/s40290-017-0210-x · Cited by 179
Educational interventions to improve prescription and dispensing of antibiotics: a systematic review
Roque, F., Herdeiro, M. T., Soares, S., Teixeira Rodrigues, A., Breitenfeld, L., & Figueiras, A. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1276 · Cited by 171
Payne, D. J., Cramp, R., Winstanley, D. J., & Knowles, D. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.767 · Cited by 171
Godman, B., Haque, M., McKimm, J., Abu Bakar, M., Sneddon, J., Wale, J., Campbell, S., Martin, A. P., Hoxha, I., Abilova, V., et al. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1700947 · Cited by 171
Self-citationSystematic Review on Irrational Use of Medicines in China and Vietnam
Mao, W., Vu, H., Xie, Z., Chen, W., & Tang, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117710 · Cited by 170
Strategies to Combat Antimicrobial Resistance
Swami, O. C. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/8925.4529 · Cited by 169
Gleckman, R., Blagg, N., & Joubert, D. W. (1981) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1981.tb03548.x · Cited by 167
Wohlleben, W., Mast, Y., Stegmann, E., & Ziemert, N. (2016) · Microbial Biotechnology · doi:10.1111/1751-7915.12388 · Cited by 164
Systematic Review of Interventions to Improve Prescribing
Ostini, R., Hegney, D. G., Jackson, C. L., Williamson, M. F., Mackson, J. M., Gurman, K., Hall, W., & Tett, S. E. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l488 · Cited by 163
Mantravadi, P. K., Kalesh, K., Dobson, R. C. J., Hudson, A. O., & Parthasarathy, A. (2019) · Antibiotics · doi:10.3390/antibiotics8010008 · Cited by 161
Kallen, A. J., Hidrón, A., Patel, J. B., & Srinivasan, A. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/652152 · Cited by 158
Maugeri, G., Lychko, I., Sobral, R., & Roque, A. C. A. (2019) · Biotechnology Journal · doi:10.1002/biot.201700750 · Cited by 158
Plasmid Detection, Characterization, and Ecology
Smalla, K., Jechalke, S., & Top, E. M. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0038-2014 · Cited by 146
Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes
Cox, G., Ejim, L. J., Stogios, P. J., Koteva, K. K., Bordeleau, E., Evdokimova, E., Sieron, A. O., Savchenko, A. V., Serio, A. W., Krause, K. M., et al. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00001 · Cited by 145
The FDA Reboot of Antibiotic Development
Shlaes, D. M., Sahm, D., Opiela, C., & Spellberg, B. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01277-13 · Cited by 143
Jacobs, T. G., Robertson, J., van den Ham, H. A., Iwamoto, K., Pedersen, H. B., & Mantel-Teeuwisse, A. K. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4359-8 · Cited by 141
Carbapenems in clinical practice: a guide to their use in serious infection
Bradley, J. S., Garau, J., Lode, H., Rolston, K. V., Wilson, S. E., & Quinn, J. P. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00094-6 · Cited by 140
Who will develop new antibacterial agents?
Cole, S. T. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0430 · Cited by 139
Cefepime: a reappraisal in an era of increasing antimicrobial resistance
Endimiani, A., Pérez, F., & Bonomo, R. A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.805 · Cited by 137
Urbaniak, C., Sielaff, A. C., Frey, K. G., Allen, J., Singh, N. K., Jaing, C. J., Wheeler, K. A., & Venkateswaran, K. J. (2018) · Scientific Reports · doi:10.1038/s41598-017-18506-4 · Cited by 137
Jairoun, A. A., Hassan, N., Ali, A., Jairoun, O., & Shahwan, M. J. (2019) · BMC Public Health · doi:10.1186/s12889-019-6878-y · Cited by 137
Antibiotic dispensing in Egyptian community pharmacies: An observational study
Sabry, N. A., Farid, S. F., & Dawoud, D. (2013) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2013.03.004 · Cited by 135
Venugopal, A. A., & Johnson, S. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir830 · Cited by 135
Shet, A., Sundaresan, S., & Forsberg, B. C. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0098-8 · Cited by 135
Antimicrobial stewardship – can we afford to do without it?
Aryee, A., & Price, N. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12417 · Cited by 134
Mshana, S. E., Matee, M. I., & Rweyemamu, M. M. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-28 · Cited by 133
Atif, M., Azeem, M., Sarwar, M. R., Shahid, S., Javaid, S., Ikram, H., Baig, U., & Scahill, S. L. (2016) · SpringerPlus · doi:10.1186/s40064-016-3615-1 · Cited by 133
Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin
Scaglione, F., & Rossoni, G. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_2.47 · Cited by 131
Shields, R. K., Nguyen, M. H., Press, E. G., Chen, L., Kreiswirth, B. N., & Clancy, C. J. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx101 · Cited by 130
Brinkman, D. J., Tichelaar, J., Graaf, S., Otten, R. H. J., Richir, M. C., & van Agtmael, M. A. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13491 · Cited by 130
Roth, L., Bempong, D. K., Babigumira, J. B., Banoo, S., Cooke, E., Jeffreys, D., Kasonde, L., Leufkens, H. G. M., Lim, J. C. W., Lumpkin, M., et al. (2018) · Globalization and Health · doi:10.1186/s12992-018-0421-2 · Cited by 127
The determinants of the antibiotic resistance process.
(2009) · Europe PMC (PubMed Central) · Cited by 126
Schilaty, N. D., Nagelli, C. V., Bates, N. A., Sanders, T. L., Krych, A. J., Stuart, M. J., & Hewett, T. E. (2017) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967117724196 · Cited by 126
Lescure, D. L. A., Paget, J., Schellevis, F., & van Dijk, L. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00370 · Cited by 122
Availability of Antibiotics for Purchase Without a Prescription on the Internet
Mainous, A. G., Everett, C. J., Post, R. E., Díaz, V. A., & Hueston, W. J. (2009) · The Annals of Family Medicine · doi:10.1370/afm.999 · Cited by 120
Predictive factors of self‐medicated drug use among the Spanish adult population
Carrasco‐Garrido, P., Jiménez‐García, R., Hernández‐Barrera, V., & de Miguel, Á. G. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1455 · Cited by 119
Using bacterial genomes and essential genes for the development of new antibiotics
Fields, F. R., Lee, S. W., & McConnell, M. J. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.12.002 · Cited by 118
Irrational use of antibiotics in the Moshi Municipality Northern Tanzania: a cross sectional study
Mboya, E. A., Sanga, L. A., & Ngocho, J. S. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.31.165.15991 · Cited by 117
Angus, B., Smith, M. D., Suputtamongkol, Y., Mattie, H., Walsh, A. L., Wuthiekanun, V., Chaowagul, W., & White, N. J. (2000) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2000.00179.x · Cited by 114
Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition
King, D. T., King, A. M., Lal, S. M., Wright, G. D., & Strynadka, N. C. J. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00007 · Cited by 113
Haque, M., Rahman, N. A. A., McKimm, J., Kibria, G. M., Majumder, M. A. A., Haque, S. Z., Islam, M. Z., Abdullah, S. L. B., Daher, A. M., Zulkifli, Z., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s203364 · Cited by 110
Self-citationIs Fidaxomicin Worth the Cost? An Economic Analysis
Bartsch, S. M., Umscheid, C. A., Fishman, N. O., & Lee, B. Y. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit346 · Cited by 108
Nelson, M. L., DiNardo, A. R., Jeffery, H., & Armelagos, G. J. (2010) · American Journal of Physical Anthropology · doi:10.1002/ajpa.21340 · Cited by 107
Gasson, J., Blockman, M., & Willems, B. (2018) · South African Medical Journal · doi:10.7196/samj.2018.v108i4.12564 · Cited by 107
Mason, T., Trochez, C., Thomas, R., Babar, M., Hesso, I., & Kayyali, R. (2018) · BMC Public Health · doi:10.1186/s12889-018-5614-3 · Cited by 104
Plachouras, D., Kavatha, D., Antoniadou, A., Giannitsioti, E., Poulakou, G., Kanellakopoulou, K., & Giamarellou, H. (2010) · Eurosurveillance · doi:10.2807/ese.15.07.19488-en · Cited by 103
Novel Approaches Are Needed to Develop Tomorrow’s Antibacterial Therapies
Spellberg, B. J., Bartlett, J., Wunderink, R. G., & Gilbert, D. N. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1894oe · Cited by 102
Hu, Y., Wang, X., Tucker, J. D., Little, P. S., Moore, M. V., Fukuda, K., & Zhou, X. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15061165 · Cited by 102
Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients
Piddock, L. J. V., Griggs, D. J., Hall, M. C., & Jin, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.662 · Cited by 101
Infection control through the ages
Smith, P. W., Watkins, K., & Hewlett, A. L. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.02.019 · Cited by 100
Plazomicin: A Next‐Generation Aminoglycoside
Shaeer, K. M., Zmarlicka, M. T., Chahine, E. B., et al. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2203 · Cited by 99
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
Eljaaly, K., Alharbi, A., Alshehri, S., Ortwine, J. K., & Pogue, J. M. (2019) · Drugs · doi:10.1007/s40265-019-1054-3 · Cited by 99
Brinkman, D., Tichelaar, J., Okorie, M., Bissell, L., Christiaens, T., Likić, R., Mačiulaitis, R., Costa, J. N., Sanz, E. J., Tamba, B.-I., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.682 · Cited by 98
Next-Generation Phenotypic Screening in Early Drug Discovery for Infectious Diseases
Aulner, N., Danckaert, A., Ihm, J., Shum, D., & Shorte, S. L. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.05.004 · Cited by 96
Shrestha, R., & Prajapati, S. (2019) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-019-0177-y · Cited by 96
Sherry, N. L., & Howden, B. P. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1453807 · Cited by 94
Accrediting retail drug shops to strengthen Tanzania’s public health system: an ADDO case study
Rutta, E., Liana, J., Embrey, M. A., Johnson, K. W., Kimatta, S. S., Valimba, R., Lieber, R., Shekalaghe, E., & Sillo, H. B. (2015) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-015-0044-4 · Cited by 92
Self-Medication with Antibiotics in Europe: A Case for Action
Grigoryan, L., Monnet, D. L., Haaijer‐Ruskamp, F. M., Bonten, M. J. M., Lundborg, S., & Verheij, T. J. (2010) · Current Drug Safety · doi:10.2174/157488610792246046 · Cited by 91
Brooks, L., Shaw, A. R. G., Sharp, D., & Hay, A. D. (2008) · Family Practice · doi:10.1093/fampra/cmn037 · Cited by 89
Junior doctors prescribing: enhancing their learning in practice
Rothwell, C., Burford, B. C., Morrison, J., Morrow, G., Allen, M. E., Davies, C., Baldauf, B., Spencer, J., Johnson, N., Peile, E., et al. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04061.x · Cited by 88
Self-citationRichir, M. C., Tichelaar, J., Geijteman, E. C. T., & de Vries, T. P. G. M. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0432-z · Cited by 88
Liu, C., Liu, C., Wang, D., & Zhang, X. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16132385 · Cited by 87
Irrational antibiotic prescribing: a local issue or global concern?
Hashemi, S., Nasrollah, A., & Rajabi, M. (2013) · EXCLI journal · doi:10.17877/de290r-10752 · Cited by 86
Smith, J. R., Rybak, J. M., & Claeys, K. C. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2378 · Cited by 86
Brennan, N., & Mattick, K. L. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04397.x · Cited by 85
Structure and mechanism of action of teicoplanin
Parenti, F. (1986) · Journal of Hospital Infection · doi:10.1016/0195-6701(86)90011-3 · Cited by 85
Control of Antimicrobial Resistance Requires an Ethical Approach
Parsonage, B., Hagglund, P. K., Keogh, L., Wheelhouse, N., Brown, R. E., & Dancer, S. J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02124 · Cited by 85
Impacto de medidas regulatorias en la tendencia de consumo comunitario de antibióticos en Chile
Luis Bavestrello, F., Ángela Cabello, M., & Dunny Casanova, Z. (2002) · Revista médica de Chile · doi:10.4067/s0034-98872002001100009 · Cited by 83
Insights into Newer Antimicrobial Agents against Gram-negative Bacteria
Yaneja, N., & Kaur, H. (2016) · Microbiology Insights · doi:10.4137/mbi.s29459 · Cited by 82
Recent advances in antibacterial drugs
Kaur, M., Rai, J., & Randhawa, G. (2013) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.112229 · Cited by 81
Avibactam and Inhibitor-Resistant SHV β-Lactamases
Winkler, M., Papp‐Wallace, K. M., Taracila, M. A., & Bonomo, R. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04405-14 · Cited by 81
Hair, P. I., & Keam, S. J. (2007) · Drugs · doi:10.2165/00003495-200767100-00008 · Cited by 79
Villegas, L. A., Otero, L., Sterling, T. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152933 · Cited by 79
Daum, R. S., Kar, S., & Kirkpatrick, P. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2442 · Cited by 79
Dooling, K. L., Kandeel, A., Hicks, L. A., El‐Shoubary, W., Fawzi, K., Kandeel, Y., Etman, A., Lohiniva, A., & Talaat, M. (2014) · Antibiotics · doi:10.3390/antibiotics3020233 · Cited by 77
Zappia, G., Menéndez, P., Monache, G. D., Misiti, D., Nevola, L., & Botta, B. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707780363783 · Cited by 76
Mechanisms of Resistance to Daptomycin in Enterococcus faecium
Montero, C. I., Stock, F., & Murray, P. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-07 · Cited by 74
Abdelaziz, A., Tawfik, A. G., Rabie, K. A., Omran, M., Hussein, M., Abou‐Ali, A., & Ahmed, A. F. (2019) · Antibiotics · doi:10.3390/antibiotics8020035 · Cited by 74
Rational use of medicines – an important issue in pharmaceutical policy
Almarsdóttir, A. B., & Traulsen, J. M. (2005) · Pharmacy World & Science · doi:10.1007/s11096-005-3303-7 · Cited by 72
Regulating the use of antibiotics in the community
Carbon, C., & Bax, R. P. (1998) · BMJ · doi:10.1136/bmj.317.7159.663 · Cited by 71
Das, S., Li, J., Riccobene, T. A., Carrothers, T. J., Newell, P., Melnick, D., Critchley, I. A., Stone, G. G., & Nichols, W. W. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02187-18 · Cited by 70
Cited by
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Self-citationAntimicrobial research productivity in Lebanon: A PubMed-Based bibliometric analysis
Hajj, A., Sacre, H., Ounsi, M., Nasser, M., Mohsen Meame, S., Hazime, H., Al-Hajje, A., Rahme, D., Lahoud, N., Safwan, J., et al. (2025) · New Microbes and New Infections · doi:10.1016/j.nmni.2025.101642 · Cited by 1
Metadata
- Authors
- Dhingra, S., Rahman, N. A. A., Peile, E., Rahman, M., Sartelli, M., Hassali, M. A., Islam, T., Islam, S., & Haque, M.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2020-11-04
- Volume
- 8
- Pages
- 535668-535668
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W3097070695
- Cited by
- 329
- References
- 253
- FWCI
- 21.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.